Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >



Bass, Berry & Sims' attorneys have served in regulatory auditor and monitor roles for some of the most preeminent companies and organizations in the world, including the New York Stock Exchange (NYSE). As government-approved monitors, our attorneys have extensive experience evaluating and monitoring the implementation of remedial measures and internal controls following allegations of unlawful conduct or deficiencies. Our team includes former U.S. Securities & Exchange Commission (SEC) and U.S. Department of Justice (DOJ) officials, including a former Assistant Chief of the DOJ's Fraud Section, Criminal Division; a former Criminal Chief, and a former Civil Chief in the U.S. Attorney's Office; a former Federal Bureau of Investigation (FBI) agent; and, an Organization for Economic Cooperation & Development (OECD) anti-corruption monitor.

Our attorneys have provided Foreign Corrupt Practices Act (FCPA) assistance to companies in a variety of sectors and many of our team members have lived and worked overseas. We understand and appreciate the cultural and compliance challenges that occur in international business and the importance of achieving compliance objectives while minimizing the effect on business operations.

We have credibility with enforcers, a proven record of independence, exceptional cost-efficiency, and we satisfy each of these key criteria for FCPA monitors:

  • Demonstrated FCPA training, counseling and internal investigations experience.
  • Extensive experience designing, reviewing and implementing FCPA policies, procedures and controls.
  • Experienced team with access to necessary resources and the ability to deploy worldwide.
  • Ready access to local counsel and resources in 120 countries with the ability to deploy worldwide through our firm's membership in Lex Mundi and SCG Legal, two of the world's leading associations of independent law firms.


View More

Related Professionals


Viewing 0 of 0 Results

View More

Media Mentions

View More




Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.